A Phase 3, Randomized, Active Controlled Study to Evaluate Maintenance of Response, Safety and Patient Reported Outcomes in Acromegaly Patients Treated With Octreotide Capsules vs. Parenteral Somatostatin Receptor Ligands

Trial Profile

A Phase 3, Randomized, Active Controlled Study to Evaluate Maintenance of Response, Safety and Patient Reported Outcomes in Acromegaly Patients Treated With Octreotide Capsules vs. Parenteral Somatostatin Receptor Ligands

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Sep 2017

At a glance

  • Drugs Octreotide (Primary) ; Cabergoline; Lanreotide
  • Indications Acromegaly
  • Focus Registrational; Therapeutic Use
  • Acronyms MPOWERED
  • Sponsors Chiasma
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 19 May 2017 This trial has been suspended Netherlands as per European Clinical Trials Database record.
    • 15 Sep 2016 Planned End Date changed from 1 Mar 2020 to 1 Mar 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top